Commenting today on the Centers for Medicare & Medicaid Services’ proposed calendar year 2023 payment rule for hospital outpatients and ambulatory surgical centers, AHA said it supports the agency’s decision to end its unlawful cuts to 340B hospitals and urged the agency to promptly restore 340B hospital payments for CYs 2018-2022 without penalizing other hospitals. AHA also voiced support for the agency’s proposal to use Medicare claims data to calculate the monthly facility rate for Rural Emergency Hospitals, and urged the agency to detail the payment methodology and monitor its adequacy going forward. 
 
However, AHA strongly urged the agency to increase the rule’s proposed market basket update and reduce its productivity adjustment to reflect the unprecedented inflationary environment hospitals and health systems are experiencing. It also urged CMS not to add facet joint interventions to its prior authorization process, as other oversight mechanisms are available that do not delay appropriate care. 
 
Among other issues, AHA commented on CMS’s proposal to exempt rural Sole Community Hospitals from the site-neutral clinic visit payment cuts; organ acquisition payments; and a request for information regarding the use of CMS data to drive competition in health care marketplaces.

Related News Articles

Headline
The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a preliminary injunction against the state’s…
Headline
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s…
Headline
The U.S. District Court for the District of Maine today issued an order denying preliminary injunctions requested by AbbVie and Novartis in legal challenges…
Headline
The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical…
Headline
The United States Court of Appeals for the Fifth Circuit Sept. 12 affirmed a Mississippi Court’s decision to deny AbbVie’s request for a preliminary injunction…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…